Leaflet MIDAZOLAM LICONSA 5mg 5mg / 1ml buccopharyngeal solution

Product code:
W67687001
Quantity:
2
Indicated for:
sedation
Route of administration:
buccopharyngeal
Substance:
midazolam (benzodiazepine)
ATC
N05CD08 — Nervous system | Hypnotics and sedatives | Benzodiazepine derivatives

Precautions:

Driving impairment

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse

Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression

Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol

Avoid alcohol

Avoid alcohol during treatment.

Avoid grapefruit

Avoid grapefruit

Avoid grapefruit and grapefruit juice.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning

Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Midazolam is a medication used for sedation, anxiety reduction, sleep induction, and seizure control. It belongs to the benzodiazepine class and works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that decreases brain activity, inducing relaxation and drowsiness.

Midazolam is commonly used in medical or surgical procedures to induce conscious sedation or general anesthesia. It is also used to treat acute seizures, including status epilepticus, and to calm agitated patients in intensive care units.

It can be administered intravenously, intramuscularly, orally, or intranasally, depending on the indication. Its effects are rapid, but its duration is relatively short, making it ideal for use in acute situations.

Common side effects include drowsiness, dizziness, confusion, low blood pressure, and respiratory depression. In high doses or when combined with other central nervous system depressants (such as alcohol or opioids), it can cause severe respiratory depression or even respiratory arrest.

Midazolam must be used under strict medical supervision, and the dosage should be adjusted based on the patient's age, weight, and overall condition. It is contraindicated in individuals with benzodiazepine allergies or severe respiratory insufficiency.

General data about MIDAZOLAM LICONSA 5mg 5mg / 1ml

Substance:
midazolam
Date of latest medicines list:
01-04-2026
Product code:
W67687001
Concentration:
5mg / 1ml
Pharmaceutical form:
buccopharyngeal solution
Packing volume:
1 ml
Product type:
Generic medicine
Prescription status:
TAB3 — Medicines dispensed with a special medical prescription for psychotropic substances, green in color.

Marketing authorisation

Manufacturer:
LABORATORIOS LICONSA S.A. - SPANIA
Holder:
DESITIN ARZNEIMITTEL GMBH - GERMANIA
Number:
13649/2021/01
Shelf life:
18 months

Concentrations available for midazolam

  • 10mg
  • 10mg/2ml
  • 1mg/ml
  • 2.5mg
  • 2.5mg/0.5ml
  • 2mg/ml
  • 5mg
  • 5mg/1ml
  • 5mg/ml
  • 7.5mg
  • 72.5mg/1.5ml